Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Or Refractory Non-Hodgkin Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05265975
What this trial is testing

ATG-010 in Combination With Lenalidomide and Rituximab (R2) in Adults With DLBCL and iNHL

Who this might be right for
Diffuse Large B-cell LymphomaIndolent Non-Hodgkin Lymphoma
Antengene Corporation 54
Early research (Phase 1)Study completedNCT03212937
What this trial is testing

Phase I Trial of Selinexor (KPT-330) and Ifosfamide, Carboplatin, Etoposide (ICE) in Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma
National Cancer Centre, Singapore 11
Testing effectiveness (Phase 2)Study completedNCT04298879
What this trial is testing

IBI376 in Patients With Relapsed or Refractory Follicular Lymphoma/Marginal Zone Lymphoma

Who this might be right for
Indolent Non-hodgkin Lymphoma
Innovent Biologics (Suzhou) Co. Ltd. 81
Testing effectiveness (Phase 2)Study completedNCT00884286
What this trial is testing

Multicenter Trial to Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin Lymphoma

Who this might be right for
LeukemiaLymphoma
PharmaMar 67
Early research (Phase 1)Looking for participantsNCT06675123
What this trial is testing

Pacritinib in Combination With a BTK Inhibitor for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma

Who this might be right for
Recurrent Mantle Cell LymphomaRefractory Mantle Cell Lymphoma
City of Hope Medical Center 10
Early research (Phase 1)Looking for participantsNCT06176690
What this trial is testing

Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas

Who this might be right for
CD30-Positive Diffuse Large B-Cell LymphomaAnaplastic Large Cell Lymphoma, T Cell and Null Cell TypeAnaplastic Large Cell Lymphoma, ALK-Positive+4 more
Baylor College of Medicine 90
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Early research (Phase 1)Study completedNCT00334438
What this trial is testing

Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
UNC Lineberger Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT01133158
What this trial is testing

R-BMD in Refractory or Relapsed Lymphoma, GELTAMO Clinical Trial

Who this might be right for
Non-Hodgkin's Lymphoma
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 61
Very early researchLooking for participantsNCT04532281
What this trial is testing

Murine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaNon-Hodgkin Lymphoma of Soft Tissue
Zhejiang University 120
Early research (Phase 1)Active Not RecruitingNCT05299164
What this trial is testing

GVM±R in Patients With Relapsed or Refractory Aggressive NHL

Who this might be right for
Non Hodgkin Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 18
Large-scale testing (Phase 3)UnknownNCT01449344
What this trial is testing

Efficacy and Safety of R-HAD Alone or in Combination With Bortezomib in Patients With Relapsed or Refractory MCL

Who this might be right for
Mantle Cell Lymphoma
Prof. Dr. M. Dreyling (co-chairman) 128
Testing effectiveness (Phase 2)Ended earlyNCT04305444
What this trial is testing

Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas

Who this might be right for
Relapsed Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic LeukemiaDiffuse Large B Cell Lymphoma+2 more
Zhejiang DTRM Biopharma 55
Early research (Phase 1)Study completedNCT02432235
What this trial is testing

Study of ADCT-301 in Patients With Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaNon-Hodgkin Lymphoma
ADC Therapeutics S.A. 133
Early research (Phase 1)Study completedNCT03527147
What this trial is testing

Platform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (PRISM Study)

Who this might be right for
NHLDLBCLNon-hodgkin's Lymphoma+1 more
Acerta Pharma BV 30
Post-approval studies (Phase 4)UnknownNCT04134247
What this trial is testing

Study of PD-1 Monoclonal Antibody in Combination With Chemotherapy in Patients With RR NHL

Who this might be right for
Relapsed/Refractory Non-Hodgkin's Lymphoma
Shandong Provincial Hospital 120
Early research (Phase 1)Study completedNCT01351935
What this trial is testing

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Who this might be right for
B Cell Non-Hodgkin's LymphomaChronic Lymphocytic LeukemiaWaldenstrom Macroglobulinemia
Celgene 113
Very early researchUnknownNCT06224049
What this trial is testing

Treatment of Relapsed or Refractory Epstein-Barr Virus Positive T-cell Lymphoma With hNeo-T

Who this might be right for
T-cell Lymphoma
BGI, China 6
Early research (Phase 1)Active Not RecruitingNCT04756726
What this trial is testing

Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma

Who this might be right for
Multiple MyelomaLymphoma, Non-Hodgkin's
C4 Therapeutics, Inc. 224
Early research (Phase 1)Study completedNCT03019055
What this trial is testing

Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, B-CellChronic Lymphocytic Leukemia+1 more
Medical College of Wisconsin 26
Next Page